News

Li-S Energy Battery Powers Pegasus Drone's Near 2-Hour Flight

Brisbane – September 30, 2026 -- The EATP Pegasus long endurance drone completed a nearly two-hour test flight covering more than 75 kilometres on a single Li-S Energy lithium sulfur battery pack, landing safely with battery capacity to spare.

Pegasus battery delivers 80% more range than comparable lithium polymer packs

On a same cell weight basis, Li-S Energy's 382 Wh lithium sulfur battery packs delivered 80% more range and flight time than an equivalent high-performance professional lithium polymer UAV battery pack, according to the company. The twin-motor, five-metre wingspan aircraft combines V-TOL Aerospace's airframe and power systems, Li-S Energy's battery packs and battery management system, and a perovskite solar array fabricated by Halocell Energy.

Virtus Solis, Brae Systems Sign First-Ever Space Solar PPA

Troy, Michigan and Chicago – September 30, 2026 -- Virtus Solis Technologies and Brae Systems have closed a 20-year Power Purchase Agreement for space-based solar power, marking the world's first commercial orbital solar PPA and a multi-billion-dollar lifetime contract commitment.

Virtus Solis will deliver 100 MW of continuous orbital solar power to Brae's subsea GPU infrastructure

Under the deal, Virtus Solis will supply 100 MW of 24/7 baseload solar power, equivalent to 876,000 MWh annually, transmitted via a dedicated receiving station to be built in Illinois. Brae holds an option to expand capacity to 250 MW, or 2.19 million MWh annually, within three years of initial commercial operations.

CUJO AI Launches Tool to Pinpoint Proxy-Hijacked Home Devices

Los Angeles – September 30, 2026 -- CUJO AI has introduced a new network intelligence capability that identifies the exact device inside a subscriber's home being used as a residential proxy, closing a detection gap that previously left operators able only to flag suspicious IP addresses without knowing which device was compromised.

New tool pairs device-level detection with remediation guidance and real-time alerts

The capability runs at the home gateway, identifying which subscriber network is hosting proxy activity and pinpointing the specific device generating it. It classifies the activity type, such as ad fraud or malware, and delivers device-specific remediation steps alongside real-time notifications to operators.

AppZen Launches AI Agents to Automate Corporate Card Compliance

San Jose – September 30, 2026 -- AppZen has launched Autonomous Cards, an AI agent layer that automates compliance, monitoring and spend intelligence for enterprise corporate card programs, as commercial card volume in the U.S. hit $2.23 trillion in 2024, up 4.5% year-over-year, according to the Nilson Report.

AppZen deploys AI agents to process transactions without replacing existing card infrastructure

Autonomous Cards connects directly to companies' existing purchasing, virtual, fleet, ghost, and lodge card programs, keeping current banks and issuers intact while adding a unified AI and compliance layer. The system continuously monitors eligible transactions, using card data, merchant details, Level 3 detail, supporting documents and company policy to determine what was purchased and whether it complies with internal rules.

Servier Standardizes Data Across 80+ Countries With Veeva OpenData

Barcelona – September 30, 2026 -- Servier is standardizing customer reference data across more than 80 countries using Veeva OpenData, part of a global push to build an AI-ready data foundation for its commercial and medical teams.

Servier scales AI infrastructure after prior success with Veeva Link Key People

The French pharmaceutical company, governed by a Foundation, is harmonizing customer reference data globally to create a unified semantic layer that connects with Veeva Link. Liam Hanrahan, director of world operations excellence at Servier, said the move goes beyond process improvement, calling it the construction of a global data foundation designed to redefine how the company operates and scale AI across its affiliates.

Dar Global Revenue Jumps 66% to $258M as GDV Hits $23bn

Riyadh – September 30, 2026 -- Dar Global, the London-listed luxury developer, posted a 66% revenue increase to US$258.0 million for the six months ended June 30, 2026, up from US$155.4 million in HY 2025.

Net profit more than doubles as margins widen across the portfolio

Gross profit climbed 85% to US$87.7 million, lifting margins to 34% from 31% a year earlier. EBITDA rose 73% to US$46.3 million, while net profit surged 149% to US$30.4 million from US$12.2 million, driven by revenue recognition on The Astera, Interiors by Aston Martin, and Neptune, Interiors by Mouawad.

TrackVia Launches AI Layer IRIS, MCP Support, Rebuilt Android App

Denver – September 30, 2026 -- TrackVia has expanded its Field Operations Intelligence platform with a new artificial intelligence layer called IRIS, enterprise AI connectivity, a rebuilt Android application and a modernized web interface, targeting organizations managing complex field operations across construction, manufacturing, healthcare, hospitality, education and government.

Skilled-trade labor shortage drives platform upgrade

An August 2026 Lightcast analysis found roughly three open skilled-trade jobs for every qualified worker available to fill them. TrackVia CEO Aylin Basom said the company is responding to that gap by investing across AI, mobility, user experience, integrations and enterprise readiness rather than adding a single AI feature.

Novo Nordisk: Wegovy Pill Switch Study Shows 8.8 lb Loss in 3 Months

Plainsboro, New Jersey – – September 30, 2026 -- Adults with overweight or obesity who switched from injectable GLP-1 therapies to the oral Wegovy pill lost an average of 4.0 kg (8.8 lb) over three months, according to new real-world data from Novo Nordisk's OCTANE study presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan on September 30, 2026.

Patients switching to the oral formulation saw rapid weight-loss gains after three months

The retrospective analysis of 194 patients on the Ro telehealth platform found that 40.7% achieved weight loss of 5% or more within three months of switching from injectable semaglutide or tirzepatide to once-daily oral semaglutide (p0.001). The proportion of participants classified with a BMI of 30 kg/m2 or higher fell by 21.6 percentage points, dropping from 87.1% at baseline to 65.5% at the three-month mark.

Ro, Novo Unveil First Real-World Data on Wegovy Pill Switch at EASD2026

New York – September 30, 2026 -- Direct-to-patient healthcare company Ro presented the first real-world evidence on Novo Nordisk's oral Wegovy pill at the EASD2026 meeting in Milan on September 30, based on outcomes from patients on its platform who switched from an injectable GLP-1.

Ro's platform generates first clinical data on Wegovy pill switch patients

The short oral session study, co-authored by Ro clinical advisors Dr. Beverly Tchang and Dr. Louis Aronne, tracked patients with overweight or obesity who transitioned from an injectable GLP-1 and remained persistent with the Wegovy pill for three months on Ro's platform.

Astrocyte Raises $9.5M Series B as Concussion Drug Trial Completes Enrollment

Groton, Conn. – September 30, 2026 -- Astrocyte Pharmaceuticals Inc. has closed a $9.5 million Series B financing round to advance Phase 2 development of AST-004, its cerebroprotective therapy for concussion, traumatic brain injury (TBI) and stroke. The round brings total capital raised by the clinical-stage biotech, including grants, to $40 million.

DeepWork Capital leads financing with four new investors joining the round

The Series B was led by DeepWork Capital, with continued backing from existing investors and new participation from MintPharma Capital, Waterstar Capital, Dynagrow Capital and Angel Star Ventures. Jackson Streeter, M.D., Venture Partner at DeepWork Capital, said the firm has been impressed by the consistency of Astrocyte's science and the progress of its clinical programs.

Subscribe to News